Joana Goncalves
Chief Tech/Sci/R&D Officer en CARA THERAPEUTICS, INC. .
Fortuna: 47 700 $ al 29/02/2024
Perfil
Joana Goncalves occupies the position of Chief Medical Officer for CARA Therapeutics, Inc.
In the past Dr. Goncalves was Vice President-Medical Affairs & Neurology at Celgene Corp.
and VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc.
Dr. Goncalves received a doctorate from the University of Cape Town.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CARA THERAPEUTICS INC
0.10% | 29/02/2024 | 56 118 ( 0.10% ) | 47 700 $ | 29/02/2024 |
Cargos activos de Joana Goncalves
Empresas | Cargo | Inicio |
---|---|---|
CARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 23/10/2018 |
Antiguos cargos conocidos de Joana Goncalves.
Empresas | Cargo | Fin |
---|---|---|
CELGENE | Chief Tech/Sci/R&D Officer | 01/10/2018 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | 01/04/2014 |
Formación de Joana Goncalves.
University of Cape Town | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |